Records containing: Thrombocytosis

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-03-09
Molecular Biology of Polycythemia and Thrombocytosis
CLINICAL_TRIALS study record update · 2020-04-15
A Phase Ib/II, Open-label, Multi-center, Dose-finding Study to Assess the Safety and Efficacy of the Oral Combination of LDE225 and INC424 (Ruxolitinib) in Patients With Myelofibrosis
CLINICAL_TRIALS study record update · 2018-05-21
Predictors of Reactive Thrombocytosis in Critically Ill Septic Patients
CLINICAL_TRIALS study record update · 2017-02-27
A Phase 2, Open Label Efficacy and Safety Study of Anagrelide Controlled Release (CR) in Subjects With Thrombocytosis Secondary to Essential Thrombocythemia and Other Myeloproliferative Neoplasms (MPN)
CLINICAL_TRIALS study record update · 2016-06-15
Multicenter, Retrospective Data Collection of Routine Clinical Use With the Spectra Optia® Apheresis System for Platelet Depletion Procedures.
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2012-08-02
A Phase 1/2, Open-Label Study of the JAK2 Inhibitor INCB018424 Administered Orally to Patients With Primary Myelofibrosis (PMF) and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis (Post-PV/ET)
CLINICAL_TRIALS study record update · 2010-09-03
The Role of Reactive Thrombocytosis in Children With Pneumococcal Infection
CLINICAL_TRIALS study record update · 2010-04-08
A Multi-centre, Randomized, Controlled, Single-blinded, Phase II Study to Investigate the Safety and Efficacy of Intravenous Infusions of FERINJECT® Versus Placebo in Patients With Thrombocytosis Secondary to Iron Deficiency and Chronic Inflammatory Bowel Disease